|  | Cancer | Pancreatic Cancer

Metastatic Renal Cell Carcinoma (RCC): Symptoms, Stages & Treatment Options

What Is Metastatic RCC?

Metastatic renal cell carcinoma (RCC) is kidney cancer that has spread beyond the kidney to distant organs such as the lungs, bones, liver, or brain. It accounts for about 90% of kidney cancers and is more common in men, with an average diagnosis age of 64.

Common Symptoms

  • Blood in urine (hematuria)
  • Persistent pain in the back, side, or abdomen
  • Unexplained weight loss
  • Fatigue and loss of appetite
  • Fever and night sweats
  • Palpable abdominal mass

Many early-stage RCCs are asymptomatic and found incidentally on imaging.

Treatment Options

Treatment is tailored to the number and location of metastases, tumor genetics, and patient health. Options include:

  • Targeted Therapy: Tyrosine kinase inhibitors (TKIs) like sunitinib, pazopanib, or cabozantinib block angiogenesis and tumor growth pathways.
  • Immunotherapy: Checkpoint inhibitors (nivolumab, ipilimumab, pembrolizumab) activate the immune system against cancer.
  • Combination Regimens: TKI plus immunotherapy (e.g., axitinib + pembrolizumab) are now standard first-line for many patients.
  • Surgery (Cytoreductive Nephrectomy): Removal of the primary kidney tumor may be considered in select patients with limited metastases.
  • Radiation Therapy: Used for palliation of painful bone or brain metastases.
  • Stereotactic Body Radiation Therapy (SBRT): High-precision radiation for oligometastatic disease.

Prognosis and Survival

The 5-year survival rate for metastatic RCC is approximately 10–15%, but outcomes have improved significantly with modern targeted and immune therapies. Factors influencing prognosis include performance status, time from diagnosis to treatment, number of metastatic sites, and laboratory values (hemoglobin, calcium, neutrophils, platelets—the IMDC criteria).

What to Expect During Treatment

  • Regular imaging (CT/MRI) every 8–12 weeks to monitor response.
  • Blood tests to assess kidney/liver function and blood counts.
  • Management of side effects: hypertension, diarrhea, fatigue, hand-foot syndrome, thyroid dysfunction, immune-related adverse events.
  • Multidisciplinary care involving medical oncology, urology, radiation oncology, radiology, and palliative care.

Lifestyle and Support

Maintain a balanced diet, stay active as tolerated, avoid smoking, and manage stress. Seek support groups, counseling, and financial navigation resources. Discuss clinical trial options with your oncologist.

Pancreatic Cancer - Related Articles